iSpecimen Inc.
About iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.9M
- Net income
- -$10.5M
- Total assets
- $9.5M
- Market cap
- $4.3M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $4.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 17, 2021
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review iSpecimen Inc..